Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that its Board of Directors Compensation Committee approved an inducement grant for Jim Hagen, Senior Vice President – Strategic Commercial Operations. …
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the European launch of its OviTex Inguinal Reinforced Tissue Matrix, the first reinforced tissue matrix explicitly designed for laparoscopic and …
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in soft tissue reconstruction innovations, has announced the appointment of Jeffrey Blizard as its new President, effective immediately. Blizard, who …
TELA Bio Names Jeffrey Blizard as President to Drive Strategic Growth Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced its participation in the 2025 Jefferies Global Healthcare Conference. The company, known for its innovative soft-tissue reconstruction solutions, continues to …
TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that its Compensation Committee approved inducement grants of restricted stock units for 6,600 shares of common stock to twelve new employees, …
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong start to 2025, with first-quarter revenue reaching $18.5 million, a 12% increase compared to the same period last year …
TELA Bio Reports Q1 2025 Growth and Product Expansion Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction, announced it will report Q1 2025 financial results on Thursday, May 8, 2025. Management …
TELA Bio to Announce Q1 2025 Earnings on May 8 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the U.S. launch of larger configurations for its OviTex PRS Reinforced Tissue Matrix, a specialized device designed to support plastic and …
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced that its Compensation Committee recently approved inducement grants of restricted stock units (RSUs) covering 7,200 shares of common stock. These grants, …
TELA Bio Announces Inducement Grants to Newly Hired Employees Read More